RIMEGEPANT 75 MG, AN ORAL CALCITONIN GENE-RELATED PEPTIDE ANTAGONIST, FOR THE ACUTE TREATMENT OF MIGRAINE: TWO PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

R. B. Lipton, V. Coric, E. G. Stock, D. A. Stock, B. A. Morris, T. J. McCormack,M. Frost,K. Gentile, C. M. Jensen,G. M. Dubowchik,C. M. Conway, R. Croop,P. J. Goadsby

CEPHALALGIA（2018）

Cited 16|Views4

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined